BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen M, Luo Y, Men L, Lin B, Lin H, Li Y, Zhong G, Zhong X, Fu W, Zhou H, Tong G, Liu Q, Luan J. Investigating the mechanisms of Modified Xiaoyaosan (tiaogan-liqi prescription) in suppressing the progression of atherosclerosis, by means of integrative pharmacology and experimental validation. Aging (Albany NY) 2021;13:11411-32. [PMID: 33839698 DOI: 10.18632/aging.202832] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Mingtai C, Guofu Z, Junteng C, Ling M, Jienan L, Zhihao L. Effectiveness and safety of Tiaogan formula in the treatment of coronary heart disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e32237. [PMID: 36550848 DOI: 10.1097/MD.0000000000032237] [Reference Citation Analysis]
2 Wang X, Liu J, Zhou P, Han Z, Meng Z, Yang H. Effects of Angelica Fritillaria Kushen Pill on Renal Function and Immune Function after Laparoscopic Radical Nephrectomy for Patients with Renal Carcinoma. J Healthc Eng 2022;2022:4082121. [PMID: 35368912 DOI: 10.1155/2022/4082121] [Reference Citation Analysis]